Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Specific considerations with the automatic implantable atrial defibrillator

W Jung1, C Wolpert, B Esmailzadeh

  • 1Department of Medicine-Cardiology, University of Bonn, Germany.

Journal of Cardiovascular Electrophysiology
|September 4, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implantation of left ventricular epicardial leads in cardiosurgical patients with impaired cardiac function--a worthwhile procedure in concomitant surgical interventions?

The Thoracic and cardiovascular surgeon·2011
Same author

Transcatheter PFO closure with a prominent Eustachian valve.

Zeitschrift fur Kardiologie·2004
Same author

Potential device interaction of a dual chamber implantable cardioverter defibrillator in a patient with continuous spinal cord stimulation.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2004
Same author

Amiodarone-associated "torsade de pointes". Relevance of concomitant cardiovascular medication in a patient with atrial fibrillation and structural heart disease.

Zeitschrift fur Kardiologie·2003
Same author

The patient's informed consent for pacemakers and ICD implantation: how to write and how to explain it.

Zeitschrift fur Kardiologie·2003
Same author

[Prevalence of intimal pathogen burden in acute coronary syndromes].

Zeitschrift fur Kardiologie·2003
Same journal

Pulsed Field Ablation Is Associated With Fewer Post-Procedural Pericardial Inflammatory Symptoms Compared With Radiofrequency Ablation.

Journal of cardiovascular electrophysiology·2026
Same journal

Single-Cell Transcriptomics and Mendelian Randomization Analysis Reveal Key Genes in Atrial Fibrillation.

Journal of cardiovascular electrophysiology·2026
Same journal

Relationship Between Nonuniform Isochrone-Area in Late Activation Mapping and Arrhythmogenic Substrates Related to Atrial Fibrillation.

Journal of cardiovascular electrophysiology·2026
Same journal

Clinical Utility of Tissue Proximity Indication With a Variable-Loop Circular Catheter for Pulmonary Vein Isolation.

Journal of cardiovascular electrophysiology·2026
Same journal

Impact of Carina Width on Re-Ablation Rate of Atrial Fibrillation After Primary Cryoballoon-Ablation.

Journal of cardiovascular electrophysiology·2026
Same journal

Mediastinal Air Entrapment During Extravascular ICD Implantation: A Preventable Cause of Elevated Shock Impedance.

Journal of cardiovascular electrophysiology·2026
See all related articles

Internal atrial defibrillation using an implantable atrial defibrillator (IAD) shows promise for treating atrial fibrillation (AF). Early results indicate safety and efficacy, though patient comfort needs improvement for wider adoption.

Area of Science:

  • Cardiology
  • Biomedical Engineering

Background:

  • Internal atrial defibrillation has been explored for over 20 years as an alternative to external methods.
  • Studies demonstrate the feasibility of internal atrial defibrillation with low energy requirements.
  • This has led to the development of the implantable atrial defibrillator (IAD).

Purpose of the Study:

  • To evaluate the safety, efficacy, and tolerability of the Metrix system for internal atrial defibrillation.
  • To assess the potential of IAD as a therapeutic alternative for specific atrial fibrillation (AF) patient subgroups.
  • To determine if IAD can maintain sinus rhythm or prolong arrhythmia-free intervals.

Main Methods:

  • Clinical experience with the Metrix system was assessed.
  • Key metrics included atrial defibrillation thresholds, R wave synchronization, and detection of atrial fibrillation (AF).

Related Experiment Videos

  • Evaluation focused on shock-induced proarrhythmia and patient tolerability.

    • Main Results:

    • The Metrix system demonstrated stable atrial defibrillation thresholds and appropriate R wave synchronization.
    • Excellent detection of atrial fibrillation (AF) with 100% specificity was observed.
    • No shock-induced ventricular proarrhythmia was reported with correctly synchronized low-energy shocks.

    Conclusions:

    • The implantable atrial defibrillator (IAD) may be a viable option for patients with drug-refractory, symptomatic, infrequent atrial fibrillation (AF).
    • Further research is needed to enhance patient comfort and increase the acceptability of internal atrial defibrillation.
    • The Metrix system shows potential as a therapeutic alternative for a specific AF patient population.